Brought to you by WBIW News and Network Indiana
Last updated on Tuesday, December 6, 2016
(INDIANAPOLIS) - Eli Lilly will begin cutting sales jobs early next year.
The company confirmed on Friday that it will begin reducing the sales staff for its U.S. bio-medicines business, which would have been responsible for selling a once-promising Alzheimer's drug called Sola.
The company didn't specify how many jobs will be cut.
Sola recently failed a clinical trial.
For more business headlines from Jane King at the Nasdaq, watch Daybreak Monday through Friday.
1340 AM WBIW welcomes comments and suggestions by calling 812.277.1340 during normal business hours or by email at comments@wbiw.com
© Ad-Venture Media, Inc. All Rights Reserved.